Carolyn Myers
Chief Executive Officer at FENDX TECHNOLOGIES INC.
Net worth: 422 020 $ as of 2024-04-29
Profile
Dr. Carolyn J.
Myers is a President, Chief Executive Officer & Director at FendX Technologies, Inc., an Independent Director at Hyloris Pharmaceuticals SA, a Principal at Bioensemble LLC and a Principal at Bio Ensemble Ltd.
She is on the Board of Directors at FendX Technologies, Inc., Hyloris Pharmaceuticals SA and EyeD Pharma SA. Dr. Myers was previously employed as a Non-Executive Director by Mayne Pharma Group Ltd., a Vice President-Global Business Development by Allergan Plc, a Vice President-CNS Marketing by Forest Laboratories, Inc., a President by Mylan Technologies, Inc., a Vice President by Mylan Laboratories, Inc., a President-Specialty Pharmaceutical Division by Mylan, Inc., a Global Director-Cardiovascular by Pharmacia, Inc., a President by Dey Laboratories, Inc., and a President by Dey Pharma LP.
She received her MBA from Rutgers State University of New Jersey, a doctorate degree from the University of British Columbia and a doctorate degree from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FENDX TECHNOLOGIES, INC.
3.11% | 2024-03-24 | 1,625,001 ( 3.11% ) | 331 500 $ | 2024-04-29 |
MAYNE PHARMA GROUP LTD.
0.02% | 2023-07-30 | 20,000 ( 0.02% ) | 90 519 $ | 2024-04-29 |
Carolyn Myers active positions
| Companies | Position | Start |
|---|---|---|
| HYLORIS PHARMACEUTICALS SA | Director/Board Member | 2019-12-31 |
| FENDX TECHNOLOGIES INC. | Chief Executive Officer | 2020-07-27 |
Bio Ensemble Ltd.
 Bio Ensemble Ltd. Miscellaneous Commercial ServicesCommercial Services Bio Ensemble Ltd. provides management and business strategy consulting services for the pharmaceutical and healthcare industry. The American company was founded by Daniel B. Vickery. | Corporate Officer/Principal | - |
EyeD Pharma SA
 EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Director/Board Member | - |
Former positions of Carolyn Myers
| Companies | Position | End |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Director/Board Member | 2023-07-30 |
| ALLERGAN PLC | Corporate Officer/Principal | 2017-02-28 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 2013-09-30 |
Mylan Specialty LP
 Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | President | 2011-06-29 |
Mylan Laboratories, Inc.
 Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Corporate Officer/Principal | 2007-10-01 |
Training of Carolyn Myers
| University of British Columbia | Doctorate Degree |
| University of Wisconsin | Doctorate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| HYLORIS PHARMACEUTICALS SA | Health Technology |
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| FENDX TECHNOLOGIES INC. | Process Industries |
| Private companies | 10 |
|---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
| Pharmacia, Inc. | |
Mylan Technologies, Inc.
 Mylan Technologies, Inc. Containers/PackagingProcess Industries Mylan Technologies, Inc. designs, develops, and manufactures transdermal drug delivery systems, and associated materials and technologies. The company is headquartered in St. Albans, VT. | Process Industries |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan Specialty LP
Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Health Technology |
Bio Ensemble Ltd.
Bio Ensemble Ltd. Miscellaneous Commercial ServicesCommercial Services Bio Ensemble Ltd. provides management and business strategy consulting services for the pharmaceutical and healthcare industry. The American company was founded by Daniel B. Vickery. | Commercial Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
| Dey Laboratories, Inc. | |
EyeD Pharma SA
EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Health Technology |
- Stock Market
- Insiders
- Carolyn Myers
